The effect of Nanocurcumin in Tinnitus

The effect of nanocurcumin in the treatment of tinnitus

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160813029327N15

Enrollment

Registered

2018-07-25

Start date

2018-05-21

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus. Tinnitus, bilateral

Interventions

Intervention 1: Intervention group: in people with inclusion criteria to be given 80mg oral Nanocurcumin softgel capsule, 4 times daily, for three month. Intervention 2: Control group: in people with

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: All of the patients with unknown cause tinnitus

Exclusion criteria

Exclusion criteria: History of head and neck surgery Pregnant or lactating women History of turmeric sensitivity Gallstones or biliary obstruction

Design outcomes

Primary

Measure	Time frame
Tinnitus Status. Timepoint: Before treatment, 4 and 12 weeks after treatment. Method of measurement: Iowa Tinnitus Primary Function Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRamin Abrishami

Islamic Azad University

r_abrishami@iaups.ac.ir+98 21226400515

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026